Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain 1 pseudogene 25 (FTH1P25) is a non-coding processed pseudogene belonging to the ferritin family, which also includes the coding genes FTH1 (ferritin heavy chain) and FTL (ferritin light chain). Pseudogenes like FTH1P25 lack the ability to produce a functional protein, but recent research suggests pseudogenes in the ferritin family may participate in the regulation of gene expression, particularly through interactions with microRNAs and as components of ceRNA networks. While ferritin proteins are crucial for intracellular iron storage and homeostasis, their pseudogenes may influence biological outcomes such as cell proliferation, survival, metastasis, and potentially drug resistance by affecting the availability or stability of parental ferritin gene transcripts, especially in contexts involving cancer and alterations of iron balance. FTH1P25 is not currently recognized as a therapeutic target, receptor, or biomarker, and there are no drugs known to act directly on it[4][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 25 (FTH1P25).